D. Raulet
Immunology · 2000–2018
A researcher in the Science corpus: 15 papers; trusts 11 researchers and is trusted by 31 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 137 citations into it; #101 of 2,160 by trust here, #251 by citations
- Oncology — 65 citations into it
- Epidemiology — 28 citations into it
Whom D. Raulet trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- A. Cerwenka
- A. Diefenbach
- Amanda M. Jamieson
- L. Lanier
- A. Moretta
- G. Trinchieri
- C. Janeway
- W. Yokoyama
- G. Dunn
- E. Benarroch
Who trusts D. Raulet overall
- I. Waldhauer
- É. Vivier
- L. Lanier
- Hugo Gonzalez
- M. Smyth
- Alex M. Abel
- Eric O Long
- A. Steinle
- W. Yokoyama
- S. Gasser
Papers from D. Raulet's perspective
Ordered by how strongly the researchers D. Raulet trusts endorse each paper. Same corpus, a different order for every researcher.
- ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. (Immunity)
- Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. (Immunity)
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants (Science)
- Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. (Blood)
- A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. (Blood)
- Molecular basis of celiac disease. (Annual Review of Immunology)
- Roles of the NKG2D immunoreceptor and its ligands (Nature reviews. Immunology)
- Licensing of natural killer cells by host major histocompatibility complex class I molecules (Nature)
- Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. (The Lancet)
- Now You See It, Now You Don't (Science's STKE)
Their papers
- The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor (2005) — 1,404 citations
- Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade (2018) — 686 citations
- Cytokine therapy reverses NK cell anergy in MHC-deficient tumors. (2014) — 187 citations
- Regulation of ligands for the NKG2D activating receptor (2013) — 815 citations
- Innate or Adaptive Immunity? The Example of Natural Killer Cells (2011) — 2,683 citations
- NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. (2008) — 872 citations
- Development and selection of γδ T cells (2007) — 165 citations
- Self-tolerance of natural killer cells (2006) — 640 citations
- A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. (2005) — 634 citations
- Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. (2004) — 889 citations
- Roles of the NKG2D immunoreceptor and its ligands (2003) — 1,461 citations
- The role of the NKG2D immunoreceptor in immune cell activation and natural killing. (2002) — 700 citations
- Regulation of the natural killer cell receptor repertoire. (2001) — 612 citations
- Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity (2001) — 1,163 citations
- Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages (2000) — 962 citations